VEA
ARNA
Virtus ETF Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,785
| Closed | -$166K | – | 418 |
|
|
2021
Q4 | $166K | Sell |
1,785
-1,393
| -44% | -$130K | 0.06% | 306 |
|
|
2021
Q3 | $189K | Sell |
3,178
-172
| -5% | -$10.2K | 0.08% | 283 |
|
|
2021
Q2 | $228K | Sell |
3,350
-923
| -22% | -$62.8K | 0.09% | 253 |
|
|
2021
Q1 | $297K | Buy |
4,273
+71
| +2% | +$4.94K | 0.13% | 242 |
|
|
2020
Q4 | $323K | Sell |
4,202
-832
| -17% | -$64K | 0.13% | 193 |
|
|
2020
Q3 | $376K | Sell |
5,034
-673
| -12% | -$50.3K | 0.2% | 176 |
|
|
2020
Q2 | $359K | Sell |
5,707
-1,943
| -25% | -$122K | 0.17% | 256 |
|
|
2020
Q1 | $321K | Sell |
7,650
-1,108
| -13% | -$46.5K | 0.13% | 219 |
|
|
2019
Q4 | $398K | Buy |
8,758
+4,174
| +91% | +$190K | 0.07% | 256 |
|
|
2019
Q3 | $210K | Sell |
4,584
-254
| -5% | -$11.6K | 0.04% | 240 |
|
|
2019
Q2 | $284K | Buy |
+4,838
| New | +$284K | 0.06% | 241 |
|
|
2016
Q4 | – | Sell |
-317,632
| Closed | -$556K | – | 197 |
|
|
2016
Q3 | $556K | Buy |
317,632
+40,025
| +14% | +$70.1K | 0.27% | 66 |
|
|
2016
Q2 | $475K | Sell |
277,607
-45,500
| -14% | -$77.9K | 0.35% | 62 |
|
|
2016
Q1 | $637K | Hold |
323,107
| – | – | 0.88% | 23 |
|
|
2015
Q4 | $614K | Buy |
+323,107
| New | +$614K | 1.69% | 14 |
|